Company Financials

Lotus Health Group Company Financials

Renminbi

business Lotus Health Group Company Company Profile

Main Stock Listing

SSE: 600186

Market Capitalization CN¥10.57 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 5, 2025

Trailing PE 39.27
Forward PE
Price to Sales TTM CN¥3.69
Price to Book MRQ CN¥5.87
Enterprise to Revenue 3.37
Enterprise to EBITDA 20.41

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin 8.88%
Operating Margin 18.57%
Return on Assets TTM 8.03%
Return on Equity TTM 17.22%

Income Statement

Revenue TTM CN¥2,864,137,216
Revenue per Share TTM CN¥1.73
Quarterly Revenue Growth 37.80%
Gross Profit TTM CN¥771,782,208
EBITDA CN¥407,914,124
Net Income to Common TTM CN¥254,360,112
Diluted EPS TTM CN¥0.15
Quarterly Earnings Growth YoY 105.20%

Balance Sheet

Total Cash MRQ CN¥1,490,532,352
Total Cash per Share MRQ CN¥0.84
Total Debt MRQ CN¥
Total Debt to Equity MRQ 44.90
Current Ratio MRQ 1.60
Book Value per Share MRQ CN¥1.00

Cash Flow

Operating Cash Flow TTM CN¥156,200,672
Levered Free Cash Flow TTM CN¥-324,200,512

600186 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding 1,794,572,141
Float Shares 1,269,632,384
Avg 10 Volume 40,698,267
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 29.78%
% Held by Institutions 1.80%

Stock Price Summary

Beta 0.14
Fifty Two Week Low CN¥2.92
Fifty Two Week High CN¥8.20
Fifty Two Week Change 42.62%
Day 50 MA CN¥6.25
Day 200 MA CN¥5.68

Dividends and Splits

Forward Annual Dividend Rate CN¥
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate CN¥0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date 2002-07-11
Last Split Factor
Last Split Date 2006-11-20